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AbstrAct
Melanotic hyperpigmentation of the mucosa secondary to radiotherapy is a rare occurrence. It is a diagnosis of exclusion. Lit-
erature review has identified only two case reports published to date. We present a case of a patient treated at our institution.
an 18-year-old male patient of Nigerian descent underwent radical radiotherapy (36 Gy in 18 daily fractions) to his right neck 
for paediatric type follicular lymphoma over a period of four weeks. He developed hyperpigmented tongue lesions during 
the third week of radiotherapy. there was no associated tongue discomfort, inflammation, infection, or pigmentation change 
elsewhere in the oral mucosa. review of medications and past medical history did not demonstrate any potential contributing 
factors. Full blood count and biochemistry, morning cortisol levels and coagulation screen were all normal apart from mild 
neutropenia and lymphopenia. His oral cavity received a mean dose of 16.4 Gy, with the right side of his tongue receiving up 
to 37.5 Gy as this was within the planning target volume (ptV). He had an excellent response to radiotherapy and remains in 
remission. the tongue lesions resolved spontaneously 3 months post treatment.
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Hyperpigmented lesions on the tongue are not 
uncommon and are associated with a wide variety 
of potential causes. These include physiological [1], 
medication-induced, such as pegylated interferon, 
ribavirin [2–4] and chemotherapy [5], endocrine 
causes, including Addison’s disease [6], malignancy 
such as malignant melanoma [7], and others [8, 9]. 
Radiotherapy is listed as a potential aetiology for 
this occurrence in only two publications [10, 11].
We describe a case report of a patient who devel-
oped melanotic hyperpigmentation of the tongue 
during radiotherapy treatment. 
case report
An 18-year-old male student of Nigerian descent 
presented with a lump in his right neck and was 
subsequently diagnosed with stage II paediatric 
type follicular lymphoma. He had a diagnosis of 
epilepsy, although was seizure-free for the previ-
ous seven years and cerebral palsy due to pre-term 
birth. He did not take any regular medications. He 
was a non-smoker and did not drink alcohol. 
At multidisciplinary team discussion, the tu-
mour was felt to be inoperable due to close prox-
imity to neurovascular structures. Chemotherapy 
was recommended; however, he declined any sys-
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temic treatment due to concerns regarding fertility. 
After much deliberation he agreed to proceed with 
a course of radical radiotherapy. Physical examina-
tion of the neck prior to commencing radiotherapy 
was significant for a 4.3 cm × 3.4 cm right neck 
lump in the submandibular region. Oral cavity ex-
amination was unremarkable. 
He was treated with fractionated volumetric arc 
radiotherapy (VMAT), using 6MV photon beams. 
The gross tumour volume (GTV) was contoured. 
The clinical target volume (CTV) was delineated 
according to involved site radiotherapy guidelines 
with a 15 mm cranio-caudal margin. A 5mm mar-
gin was applied to form the planning target vol-
ume (PTV), as per our institutional protocol. The 
prescription dose was 36 Gy in 18 daily fractions, 
treating five days per week over a period of 4 weeks. 
During the third week of radiotherapy he devel-
oped hyperpigmented lesions on his oral tongue, 
as shown in Figure 1. On examination, these dark 
macules were located on the dorsum and lateral 
borders of the tongue. The mucosa of the tongue 
was intact with no signs of infection or inflamma-
tion. On palpation, the tongue was non-tender and 
of normal texture. The rest of the oral cavity was 
clear, with no signs of mucositis and there were 
no hyperpigmented lesions elsewhere. The lesions 
did not cause him any symptoms, specifically, they 
did not cause him any pain nor did they affect his 
taste. The radiotherapy plan was reviewed. The do-
simetric distribution of radiotherapy delivered to 
the oral cavity is illustrated in Figure 2. The right 
posterolateral tongue was included in the PTV, and 
so the maximum dose received by the tongue was 
37.5 Gy. The entire oral cavity received a minimum 
of 6.8 Gy, while the mean dose delivered was 16.4 
Gy. He had no systemic symptoms and otherwise 
was tolerating radiotherapy very well.
Review of medications and past medical history 
did not demonstrate any potential aetiology for the 
hyperpigmented lesions. Full blood count and bio-
chemistry, morning cortisol levels and coagulation 
screen were all normal apart from mild neutropenia 
and lymphopenia. A dermatology consult was ob-
tained and we planned to observe the lesions while 
he remained asymptomatic but to biopsy should he 
develop any symptoms.
As he was otherwise well we continued his course 
of radiotherapy as planned with no interruptions. 
The hyperpigmented lesions began to resolve spon-
taneously following completion of radiotherapy 
and had resolved completely by three months (Fig-
ure 1). He remains well and cancer-free at 2.5 years 
post treatment, with no recurrence of the tongue 
lesions.
Discussion
This case describes the rare phenomenon of ra-
diotherapy-induced melanotic hyperpigmentation 
of the tongue. It is a diagnosis of exclusion. Hyper-
pigmentation of the tongue has been reported in 
multiple publications, however, the authors could 
only find two publications which describe this oc-
currence as a direct result of radiotherapy [10, 11]. 
One paper by Amdur et al. [10] reports on three 
patients of African American ethnicity undergoing 
radiotherapy to the brain who developed hyper-
Figure 1. our patient’s tongue during week three of radiotherapy (left) and three months following completion of radiotherapy 
(right) 
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pigmentation of the tongue. All patients received 
low dose radiotherapy to the oral cavity due to exit 
beam dose. There was no associated mucositis or 
other oral cavity side effects. The hyperpigmenta-
tion was limited to the oral tongue. It developed 
near the end of the five to six week course, gradually 
faded after three months and completely resolved 
by twelve months. 
Barrett et al. [11] reported hyperpigmentation 
of the buccal mucosa and dorsum of the tongue of 
a Caucasian male. This occurred six months fol-
lowing completion of radical radiotherapy to meta-
static carcinoma in the cervical lymph nodes. The 
oral cavity was included within the target volume 
for this patient and he experienced side effects of 
diffuse mucositis, dry mouth and oral discomfort 
related to the high dose of radiation received. The 
hyperpigmentation subsequently progressed within 
a few months to the lateral border of the tongue 
with hyperkeratosis. Incisional biopsy demon-
strated interspersed areas of epithelial atrophy and 
hyperparakeratosis, candida infection, increased 
melanin deposition within basal keratinocytes and 
pigmentary incontinence, in addition to scattered 
abnormal irradiation fibroblasts but no vascular 
changes typical of irradiation. 
In our patient the dose to the oral cavity and 
tongue was due to the location of PTV. While the 
right side of his tongue received a higher radia-
tion dose compared to the left side, the distribution 
of hyperpigmentation was even throughout the 
tongue. 
The pathophysiology of melanotic hyperpigmen-
tation of the tongue secondary to radiotherapy is 
unclear; however, it appears to be a temporary phe-
nomenon with spontaneous resolution after a pe-
riod of months. Melanin is produced in epidermis, 
hair follicles, cochleae, eyes (choroid, irises, retinal 
pigment epithelium), heart, lung and brain (lep-
tomeninges, sustantia nigra, locus coerulus) [12]. 
Its production is not limited to melanocytes and 
ectopic synthesis in adipose tissue has been report-
ed [13]. Our patient did not have a biopsy, which 
would have definitively proven the pigmentation 
was secondary to melanin production. It is unusual 
that the hyperpigmented macules just appeared in 
the tongue of our patient, and not other areas where 
melanocytes are located, including the rest of the 
oral cavity. This was also the case in the paper by 
Amdur et al. [10]. 
Our patient’s presentation is similar to that docu-
mented by Amdur et al. [10], in terms of ethnicity, 
timing and anatomical distribution of hyperpig-
mentation. It is markedly different from that re-
ported by Barrett et al. [11], raising the possibil-
ity for differing pathophysiology. Ethnicity may be 
relevant to our patient’s presentation due to the 
increased activity of melanocytes in African, Asian 
and Mediterranean populations, which increases 
the preponderance of physiologic pigmentation in 
these populations [1, 14]. Barrett et al. [11] suggest 
that radiation-induced inflammation may cause 
stimulation of melanocytes, resulting in hyperpig-
mentation. 
Figure 2. axial (left) and sagittal (right) dosimetric distribution of radiotherapy delivered to the oral cavity in our patient’s 
radiotherapy plan. contours: ptV (red), oral cavity (cyan)
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conclusion
Melanotic hyperpigmentation of the tongue sec-
ondary to radiotherapy is a rare phenomenon; how-
ever, it does occur. It is a diagnosis of exclusion and 
it is essential that affected patients are investigated 
fully by means of a comprehensive history, clinical 
examination and laboratory tests, with consider-
ation for biopsy and radiological investigations if 
clinically appropriate. It is a potential side effect of 
radiotherapy to the head and neck region, and clini-
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